Bluebird bio, Inc. and Celgene Corporation announced initial data from the ongoing Phase 1 clinical study of bb21217 (CRB-402), an...
Read more
Celltrion, Inc. announced that the EMA has accepted for review of the Extension Marketing Authorisation Application for ‘Remsima SC’, the...
Read more
QPS, a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development, announced the expansion of its U.S.-based...
Read more
Shire plc the leading global biotechnology company focused on rare diseases, announced that the European Commission (EC) has granted Marketing...
Read more
GE Healthcare announced the opening of a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in...
Read more
Merck, known as MSD outside the United States and Canada, announced that the EC has approved DELSTRIGO™ and PIFELTRO™ for...
Read more
Sandoz, a Novartis division and the pioneer and global leader in biosimilars, announced that the European Commission (EC) granted marketing...
Read more
Arsanis, Inc. and privately-held X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics...
Read more
AMAL Therapeutics SA , a Swiss biotech developing peptide-based therapeutic cancer vaccines, announces that it has completed the second closing...
Read more
Oriented research and development of new products to lead the new trend of nutrition and health. Nestle held the “Nestle...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
